| Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. | |
| | |
MedLine Citation:
|
PMID: 19875471 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND PURPOSE: PCT studies hold short-term predictive value in patients treated with chemoradiotherapy. Our aim was to examine the long-term predictive value of baseline PCT studies for local tumor control and overall survival in SCCA of the upper aerodigestive tract treated with chemoradiotherapy. MATERIALS AND METHODS: Eighty-four patients with advanced SCCA underwent PCT followed by concomitant chemoradiation. The acquired perfusion maps represented BF, BV, MTT, and PS. Visual analysis of the parametric maps for identification of tumor perfusion patterns was conducted. ROC curves, t tests, and Kaplan-Meier survival curves were plotted for local disease control and overall survival. RESULTS: The median time of local tumor control was 24 months. The BF and PS values were significantly higher in patients who had no recurrence than in those with local failure (P < or = .02). The BF and PS were predictive (P < or = .0006) but BV and MTT held no significant predictive values for local tumor control. The patients with high BF and PS had a longer local tumor control than the patients with hypoperfused tumors (P = .0007). A visually detected BF-BV mismatch had a sensitivity/specificity of 63%/66% (P = .03) and 59%/69% (P = .03) for local tumor control and OS, respectively. Patients without mismatch lived significantly longer than patients with mismatch (P = .01). CONCLUSIONS: BF, PS, and mismatch of BF-BV are significant predictors of local tumor control after chemoradiation in SCCA of the upper aerodigestive tract. |
| | |
Authors:
|
S Bisdas; Z Rumboldt; K Surlan-Popovic; M Baghi; T S Koh; T J Vogl; M G Mack |
Publication Detail:
|
Type: Clinical Trial; Journal Article Date: 2009-10-29 |
Journal Detail:
|
Title: AJNR. American journal of neuroradiology Volume: 31 ISSN: 1936-959X ISO Abbreviation: AJNR Am J Neuroradiol Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-16 Completed Date: 2010-06-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8003708 Medline TA: AJNR Am J Neuroradiol Country: United States |
Other Details:
|
Languages: eng Pagination: 576-81 Citation Subset: IM |
Affiliation:
|
Department of Neuroradiology, Eberhard Karls University, T?bingen, Germany. Sotirios.Bisdas@med.uni-tuebingen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Antineoplastic Agents / therapeutic use Carcinoma, Squamous Cell / mortality, radiography*, therapy* Combined Modality Therapy Female Follow-Up Studies Humans Kaplan-Meiers Estimate Male Middle Aged Neoplasm Recurrence, Local / radiography Oropharyngeal Neoplasms / mortality, radiography*, therapy* Predictive Value of Tests Prospective Studies ROC Curve Radiotherapy Sensitivity and Specificity Tomography, X-Ray Computed / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
| Comments/Corrections | |
Comment In:
|
AJNR Am J Neuroradiol. 2010 Mar;31(3):391-3
[PMID:
19926707
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dynamic 320-Section CT Angiography in Cranial Arteriovenous Shunting Lesions.
Next Document: Diffusion MR Imaging of Hypoglycemic Encephalopathy.